There is 1 version of this bill. View text

Click the check-box to add or remove the section, click the text link to scroll to that section.
Titles Actions Overview All Actions Cosponsors Committees Related Bills Subjects Latest Summary All Summaries

Titles (2)

Short Titles

Short Titles - House of Representatives

Short Titles as Introduced

Personal Drug Importation Fairness Act of 2017

Official Titles

Official Titles - House of Representatives

Official Title as Introduced

To reduce prescription drug costs by allowing the importation and reimportation of certain drugs.

Actions Overview (1)

Date Actions Overview
02/07/2017Introduced in House

All Actions (3)

Date All Actions
02/10/2017Referred to the Subcommittee on Health.
Action By: Committee on Energy and Commerce
02/07/2017Referred to the House Committee on Energy and Commerce.
Action By: House of Representatives
02/07/2017Introduced in House
Action By: House of Representatives

Cosponsors (1)

* = Original cosponsor
CosponsorDate Cosponsored
Rep. Rohrabacher, Dana [R-CA-48]* 02/07/2017

Committees (1)

Committees, subcommittees and links to reports associated with this bill are listed here, as well as the nature and date of committee activity and Congressional report number.

Committee / Subcommittee Date Activity Related Documents
House Energy and Commerce02/07/2017 Referred to
House Energy and Commerce Subcommittee on Health02/10/2017 Referred to

No related bill information was received for H.R.934.

Subjects (16)

Latest Summary (1)

There is one summary for H.R.934. View summaries

Shown Here:
Introduced in House (02/07/2017)

Personal Drug Importation Fairness Act of 2017

This bill allows a drug to be imported by a person other than the drug's manufacturer if the drug: (1) has the same active ingredients, route of administration, and strength as an approved drug; (2) may be lawfully marketed in, and is imported or reimported from, a country included on a list in this Act that the Food and Drug Administration determines has standards for ensuring drug safety and effectiveness that are at least as protective as U.S. standards; (3) is dispensed by a licensed pharmacist; (4) is shipped directly to, or is imported by, the ultimate consumer; (5) is shipped or imported in quantities that do not exceed a 90-day supply; (6) is accompanied by a copy of a valid prescription; and (7) is not a controlled substance.